ClinicalTrials.govpublic full text
Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden
primary mds (very low, low or intermediate ipss-r with <5% blasts), anemia, myelodysplastic syndromes, hemoglobin (hb), low risk myelodysplastic syndrome, low risk mds, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 838357
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.